Form 4: Agios Pharmaceuticals Director Kaye I. Foster-Cheek Sells Shares

Director Kaye I. Foster-Cheek of Agios Pharmaceuticals sold shares of common stock in multiple transactions on March 5th and 6th, 2024.

Summary

• Kaye I. Foster-Cheek, a director of Agios Pharmaceuticals, sold shares of the company's common stock.
• On March 5, 2024, 300 shares were sold at a price of $32.21 per share.
• On March 6, 2024, 4,415 shares were sold at a weighted average price of $31.99, with prices ranging from $31.99 to $32.04.
• Following these transactions, Ms. Foster-Cheek directly owns 6,809 shares and indirectly owns 2,200 shares through the Foster Family Revocable Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports the sale of shares by a director. It doesn't inherently indicate positive or negative sentiment towards the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for directors and officers of publicly traded companies. The information is used by investors to gauge sentiment and potential future stock performance, although single transactions are not necessarily indicative of a trend.

Stakeholder Impact

• Shareholders may interpret the sale as a lack of confidence, but it could also be for personal financial reasons.

Key Dates